Asthma 5 | The percentage of patients with asthma who smoke, and whose notes contain a record that smoking cessation advice or referral to a specialist service, if available, has been offered within the last 15 months |
Asthma 7 | The percentage of patients aged 16 or over with asthma who have had influenza immunisation in the preceding 1 September to 31 March |
BP 3 | The percentage of patients with hypertension who smoke, whose notes contain a record that smoking cessation advice or referral to a specialist service, if available, has been offered at least once |
BP 5 | The percentage of patients with hypertension in whomthe last blood pressure (measured in the last 9months) is 150/90 or less |
CHD 4 | The percentage of patients with coronary heart disease who smoke, whose notes contain a record that smoking cessation advice or referral to a specialist service, where available, has been offered within the last 15 months |
CHD 6 | The percentage of patients with coronary heart disease in whomthe last blood pressure reading (measured in the last 15 months) is 150/90 or less |
CHD 8 | The percentage of patients with coronary heart disease whose lastmeasured total cholesterol (measured in last 15 months) is 5mmol/l or less |
CHD 9 | The percentage of patients with coronary heart disease with a record in the last 15 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded) |
CHD 10 | The percentage of patients with coronary heart disease who are currently treated with a beta blocker (unless a contraindication or side-effects are recorded) |
CHD 11 | The percentage of patients with a history of myocardial infarction (diagnosed after 1 April 2003) who are currently treated with an ACE inhibitor |
CHD 12 | The percentage of patients with coronary heart disease who have a record of influenza immunisation in the preceding 1 September to 31 March |
COPD 5 | The percentage of patients with COPD who smoke, whose notes contain a record that smoking cessation advice or referral to a specialist service, if available, has been offered in the past 15 months |
COPD 8 | The percentage of patients with COPD who have had influenza immunisation in the preceding 1 September to 31 March |
DM4 | The percentage of patients with diabetes who smoke and whose notes contain a record that smoking cessation advice or referral to a specialist service, where available, has been offered in the last 15 months |
DM6 | The percentage of patients with diabetes in whomthe last HbA1C is 7.4 or less (or equivalent test/reference range depending on local laboratory) in last 15 months |
DM7 | The percentage of patients with diabetes in whomthe last HbA1C is 10 or less (or equivalent test/reference range depending on local laboratory) in last 15 months |
DM12 | The percentage of patients with diabetes in whomthe last blood pressure is 145/85 or less |
DM15 | The percentage of patients with diabetes with proteinuria ormicro-albuminuria who are treated with ACE inhibitors (or A2 antagonists) |
DM17 | The percentage of patients with diabetes whose last measured total cholesterol within the previous 15 months is 5 or less |
DM18 | The percentage of patients with diabetes who have had influenza immunisation in the preceding 1 September to 31 March |
LVD 3 | The percentage of patients with a diagnosis of CHD and left ventricular dysfunction who are currently treated with ACE inhibitors (or A2 antagonists) |
Stroke4 | The percentage of patients with a history of TIA or stroke who smoke and whose notes contain a record that smoking cessation advice or referral to a specialist service, if available, has been offered in the last 15 months |
Stroke 6 | The percentage of patients with a history of TIA or stroke in whomthe last blood pressure reading (measured in last 15 months) is 150/90 or less |
Stroke 8 | The percentage of patients with TIA or stroke whose lastmeasured total cholesterol (measured in last 15 months) is 5mmol/l or less |
Stroke 9 | The percentage of patients with a stroke shown to be non haemorrhagic, or a history of TIA, who have a record that aspirin, an alternative anti-platelet therapy, or an anticoagulant is being taken (unless a contraindication or side-effects are recorded) |
Stroke 10 | The percentage of patients with TIA or stroke who have had influenza immunisation in the preceding 1 September to 31 March |